North America Liver Cancer Drug Market Size & Outlook
North America liver cancer drug market, 2018-2030 (US$M)
North America liver cancer drug market highlights
- The North America liver cancer drug market generated a revenue of USD 948.6 million in 2021.
- The market is expected to grow at a CAGR of 14.4% from 2022 to 2030.
- In terms of segment, targeted therapy was the largest revenue generating drug class in 2021.
- Targeted Therapy is the most lucrative drug class segment registering the fastest growth during the forecast period.
North America data book summary
| Market revenue in 2021 | USD 948.6 million |
| Market revenue in 2030 | USD 3,180.3 million |
| Growth rate | 14.4% (CAGR from 2021 to 2030) |
| Largest segment | Targeted therapy |
| Fastest growing segment | Targeted Therapy |
| Historical data covered | 2018 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Targeted Therapy |
| Key market players worldwide | Bayer AG, Bristol-Myers Squibb Co, Eisai Co Ltd, Merck KGaA, Exelixis Inc |
Other key industry trends
- In terms of revenue, North America region accounted for 43.5% of the global liver cancer drug market in 2021.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,453.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Liver Cancer Drug Market Scope
Liver Cancer Drug Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America liver cancer drug market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to liver cancer drug market will help companies and investors design strategic landscapes.
Targeted therapy was the largest segment with a revenue share of 100% in 2021. Horizon Databook has segmented the North America liver cancer drug market based on targeted therapy covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to North America liver cancer drug market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America liver cancer drug market databook
-
Our clientele includes a mix of liver cancer drug market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America liver cancer drug market , including forecasts for subscribers. This continent databook contains high-level insights into North America liver cancer drug market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
